What Is Biofiller? Evidence, Uncertainty and Risks

What is biofiller? The term describes autologous plasma gel prepared from a patient's blood using protocols that are not uniform. Small studies report short-term volume and appearance changes, but samples are limited; the ideal preparation, number of sessions and duration remain uncertain. Being blood-derived does not remove risks such as infection, nodules, asymmetry, bruising or injection into a vessel. Results cannot be guaranteed. Suitability and alternatives can be discussed only after a medical assessment at the Maslak clinic in Istanbul.

Understanding Biofiller: Definition and Science

Biofiller is an autologous (self-derived) filling material produced from the patient's own blood through a specialized processing technique. After a small blood sample is drawn, it undergoes centrifugation and controlled heating to create a fibrin-based gel. Unlike hyaluronic acid fillers, which are synthetically manufactured, biofiller is entirely biological in composition and contains natural growth factors that stimulate tissue regeneration.

How Biofiller Differs from Conventional Fillers

Conventional dermal fillers typically consist of hyaluronic acid, calcium hydroxylapatite, or poly-L-lactic acid. While these materials are effective and widely used, they are exogenous substances. Biofiller uses the patient's own plasma transformed into an injectable gel. This origin does not establish a lower risk of allergy, granulomas or immune reactions than other fillers; the exact preparation and the patient's history matter.

Hyaluronic acid fillers provide immediate volume and typically last 6 to 18 months. Biofiller offers a more gradual effect; while some initial volume is noticeable, the primary benefits emerge over weeks as the growth factors stimulate collagen production. This dual mechanism — providing both volume and tissue regeneration — distinguishes biofiller from purely volumizing fillers. In some treatment plans, biofiller is combined with PRP therapy to enhance the regenerative response.

Composition and Preparation

The biofiller preparation process begins with drawing approximately 8 to 16 ml of blood from the patient's arm. This blood is placed into specialized tubes and processed in a centrifuge at carefully calibrated speed and duration. Following centrifugation, the separated plasma undergoes controlled thermal activation, transforming it from a liquid into a gel consistency suitable for injection.

The resulting biofiller material contains platelets, fibrin, and a concentrated mix of growth factors including PDGF (Platelet-Derived Growth Factor), TGF-beta (Transforming Growth Factor), and VEGF (Vascular Endothelial Growth Factor). These bioactive compounds work synergistically to promote cellular renewal and collagen synthesis at the treatment site. The entire preparation takes approximately 20 to 30 minutes and is performed under strict sterile conditions.

Who Is a Candidate for Biofiller Treatment?

People considering biofiller for facial volume loss or fine lines need an individual assessment. A previous reaction to another filler does not automatically make plasma gel suitable or safer. Tell the clinician which product caused the reaction and what symptoms occurred.

Under-eye hollows and dark circles respond well to the gentle volumizing and regenerative effects of biofiller. Cheek volume restoration, perioral fine lines, and improvement of nasolabial folds are among the frequently treated areas. Additionally, the dorsum of the hands can benefit from improved skin quality and subtle volume enhancement. For patients addressing the eye area, complementary results may be achieved alongside blepharoplasty when indicated.

However, biofiller is not recommended for individuals with active skin infections at the treatment site, bleeding disorders, or those taking blood-thinning medications. Patients with autoimmune conditions require careful evaluation before proceeding. The treatment is also not performed during pregnancy or breastfeeding. A thorough consultation ensures that each patient receives appropriate recommendations based on their health profile and aesthetic goals.

How Is the Biofiller Procedure Performed?

The biofiller application process involves several steps and typically takes 45 to 60 minutes from start to finish. The procedure requires a clinical setting and sterile technique, but these precautions do not eliminate complications.

First, a small volume of blood is drawn from the patient's arm — comparable to a routine blood test. The blood is then processed through centrifugation and thermal activation to produce the biofiller gel. While the material is being prepared, a topical anesthetic cream is applied to the treatment areas to minimize discomfort during injection.

Once both the biofiller and the treatment site are ready, the physician injects the gel into the targeted areas using fine needles or blunt-tipped cannulas. The choice of injection tool depends on the treatment area and the physician's assessment. During the procedure, the doctor carefully controls the volume and distribution of the material to achieve balanced, natural-looking results. A gentle massage following injection helps ensure even distribution of the filler.

Biofiller can be combined with complementary treatments such as PRP, mesotherapy, or botulinum toxin applications as part of a comprehensive rejuvenation plan. The specific combination depends on the patient's individual needs and the physician's clinical judgment.

Recovery and What to Expect After Biofiller

Recovery after biofiller treatment is generally straightforward, with minimal disruption to daily life. Most patients can resume their normal activities on the same day. Nevertheless, following certain aftercare guidelines helps optimize results and minimize side effects.

Mild redness, swelling, and occasional small bruises at the injection sites are common and typically resolve within 2 to 3 days. Patients should avoid intense physical exercise, saunas, swimming pools, and steam rooms for the first 24 hours. Applying makeup to the treated area is not recommended on the day of the procedure. Sun exposure should be limited for at least one week, and sunscreen use is advised when outdoors.

Some people may notice an early volume change, but its extent and persistence are uncertain. Small, heterogeneous studies do not establish a standard session count or interval; any plan requires assessment of the exact product and protocol. The studies linked below and indexed in PubMed report preliminary, short-term findings. They do not establish a predictable duration for every plasma-gel preparation. The need for further treatment should be reassessed individually; neither a fixed maintenance schedule nor sustained improvement can be promised.

Risks and Safety Considerations

Using your own blood does not remove infection, nodule, asymmetry or vascular risks from preparation and injection. During or after a facial injection, unusual pain, sudden vision changes, an abnormal white, grey or blue change in skin near the injection site, or new weakness or speech difficulty need immediate medical assessment. Seek emergency medical care without delay and notify the treating clinic; do not wait for a routine appointment or an online reply.

Swelling, redness and bruising can occur at injection sites. Infection, nodules, asymmetry or uneven distribution may also occur and may need additional treatment. Sterile technique reduces contamination risk but does not eliminate infection. Correction of a complication is not guaranteed.

The quality of the biofiller material depends directly on the preparation protocol. Non-standard equipment or incorrect centrifugation parameters can compromise the quality and safety of the final product. For this reason, it is essential that biofiller treatment is performed by a qualified physician using certified equipment. Choosing a practitioner experienced in aesthetic procedures and injection techniques is fundamental to both safety and the quality of results.

Related guides

• Under-eye filler risks
• Periocular rejuvenation options

Sources

• Assessment of platelet poor plasma gel as autologous dermal filler — PubMed
• Plasma rich in growth factor gel for facial volume restoration — PubMed

This content provides general information, not a diagnosis or personal treatment recommendation. Suitability, risks and alternatives require an individual medical assessment.